Serping1 - serine (or cysteine) peptidase inhibitor, clade G, member 1 Gene
Also Known as C1nh; C1INH
Species: Mus musculus
Summary
Enables complement binding activity and serine-type endopeptidase inhibitor activity. Predicted to be involved in negative regulation of complement activation, lectin pathway and negative regulation of endopeptidase activity. Predicted to act upstream of or within several processes, including complement activation, classical pathway; fibrinolysis; and negative regulation of peptidase activity. Located in extracellular space. Is expressed in several structures, including genitourinary system; neural ectoderm; notochord; pancreas mesenchyme; and visceral pericardium. Human ortholog(s) of this gene implicated in several diseases, including COVID-19; angioedema (multiple); cerebral infarction; pancreatitis; and toxic shock syndrome. Orthologous to human SERPING1 (Serpin family G member 1). [provided by Alliance of Genome Resources, Apr 2022]
Serping1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_009776.3 | NP_033906.2 | plasma protease C1 inhibitor precursor |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables complement binding |
IPI
IPI: Inferred from physical interaction
|
9652403 | MGI |
| enables serine-type endopeptidase inhibitor activity |
IDA
IDA: Inferred from direct assay
|
9199246 | MGI |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in extracellular space |
IDA
IDA: Inferred from direct assay
|
9652403 | MGI |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
plasma protease C1 inhibitor |
|
|
Recombinant Serping1 Proteins
| Cat. No. | 상품명 | Accession | Purity |
|---|---|---|---|
| HY-P71297 | Serpin G1 Protein, Mouse (HEK293, His) | P97290 (A20-G504) | ≥ 95%, as determined by reducing SDS-PAGE. |